Campbell & Co Investment Adviser’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Campbell & Co Investment Adviser's LLY Position: Q2 2026 in Review
Campbell & Co Investment Adviser reduced its Eli Lilly (LLY) stake by 48% in Q2 2026, selling an estimated $3.43M and leaving 3,682 shares worth $4.42M. The position accounts for 0.23% of the portfolio, ranked #101.
Campbell & Co Investment Adviser first reported a position in LLY in Q2 2013 and has held it in 16 quarters since. The position peaked at $9.3M in Q2 2013. 4,634 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Campbell & Co Investment Adviser held 3,682 shares of Eli Lilly worth $4.42M as of Q2 2026.
- Campbell & Co Investment Adviser sold 3,359 Eli Lilly shares in Q2 2026, an estimated $3.43M.
- Eli Lilly made up 0.23% of Campbell & Co Investment Adviser's portfolio in Q2 2026, its #101 holding.
- Campbell & Co Investment Adviser first reported a position in Eli Lilly in Q2 2013 and has held it in 16 quarters since.
- Campbell & Co Investment Adviser's Eli Lilly position peaked at $9.3M in Q2 2013.
- 4,634 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Campbell & Co Investment Adviser's 13F filing for Q2 2026, filed 3 Aug 2026.